Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-351-8 | CAS number: 2422-91-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 404 (Acute Dermal Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- Himalayan
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: LPT Laboratory of Pharmacology and Toxicology KG, 24601 Löhndorf/Post Wankendorf, Germany
- Age at study initiation: appr. 4.5 months
- sex: males - Type of coverage:
- semiocclusive
- Preparation of test site:
- other: shaved intact
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: surrounding untreated skin served as control
- Amount / concentration applied:
- Amount: 0.5 ml
- Duration of treatment / exposure:
- 4 hours
- Observation period:
- 1, 24, 48, 72 hours, and 4 to 13 days after patch removal
- Number of animals:
- 3
- Details on study design:
- TEST SITE
- Area of exposure: approx. 6 cm²
- Type of wrap if used: non irritating tape
REMOVAL OF TEST SUBSTANCE
- Time after start of exposure: 4 hours
SCORING SYSTEM: Draize - Irritation parameter:
- other: light brown discolouration
- Basis:
- other: all 3 animals
- Time point:
- other: from patch removal up to 8 days
- Remarks on result:
- other: Due to light brown discolouration of the application area no evaluation of erythema and oedema formation was possible.
- Irritation parameter:
- other: induration
- Basis:
- animal #1
- Time point:
- other: 1 day up to 5 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: induration
- Basis:
- animal #2
- Time point:
- other: 3 up to 5 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: induration
- Basis:
- animal #3
- Time point:
- other: up to 5 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: laceration
- Basis:
- animal: #1, #3
- Time point:
- other: 6 to 9 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: laceration
- Basis:
- animal #2
- Time point:
- other: 5 to 8 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: peeling
- Basis:
- animal #1
- Time point:
- other: 10 to 12 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: peeling
- Basis:
- animal #2
- Time point:
- other: 9 to 10 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: peeling
- Basis:
- animal #3
- Time point:
- other: 10 and 11 days
- Remarks on result:
- other: see above
- Irritation parameter:
- other: erythema/oedema score
- Basis:
- animal: #1, #2, #3
- Time point:
- other: 9 days to 13 days after patch removal
- Score:
- 0
- Max. score:
- 4
- Other effects:
- There were no systemic intolerance reactions.
- Conclusions:
Classification: not irritating- Executive summary:
Triphenylmethane-4,4',4''-triisocyanate (applied as a 27% solution in ethyl acetate) was shown to be irritating to the rabbit's skin in a study performed according to OECD TG 404. Due to light brown discolouration of the application area no evaluation of erythema and oedeme formation was possible in all 3 animals from the time point of patch removal to 8 days after patch removal. Thereafter the erythema/oedema score was 0 in all animals. On the other hand induration, laceration and peeling was observed in all animals whereas the onset of the effects differ from 24 hours to 5 days after patch removal. All effects were reversible within 13days after patch removal. No systemic intolerance reactions were observed.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Principles of method if other than guideline:
- The HCE model is currently involved in the eye irritation validation conducted by COLIPA following ECVAM guidelines. Furthermore, it is routinely used by the major Cosmetic and Pharmaceutical companies, and has already been prevalidated in 2004 (van Goethem et. al., Tox in Vitro 20, 2006, 1-17). This model is recognized as the model of choice and scientifically relevant as documented by several publications (Cotovio et. al., Tox. in Vitro, 24, 2010, 523-537).
- GLP compliance:
- yes
- Species:
- other: Assessment of ocular irritation potential of the test substance by determination of cytotoxic effects on a human corneal epithelium (HCE) cell model (exposure 60 min./rt followed by 16 hours incubation at 37 °C, subsequently MTT).
- Strain:
- other: not applicable
- Details on test animals or tissues and environmental conditions:
- The experiment was carried out on a Human Corneal Epithelial (HCE) Model, which is standardized and commercially available (SkinEthic, France). Inserts were of 0.5 cm² size. When cultivated at the air-liquid interface in a chemically defined medium, the immortalized human cornea epithelial cells reconstruct a corneal epithelial tissue (mucosa), without a stratum corneum, ultra-structurally (tissue morphology and thickness) similar to the corneal mucosa of the human eye.
- Vehicle:
- other: ethyl acetate
- Controls:
- other: as negative control: Phosphate Buffered Saline (PBS, 30 µL) as vehicle control: ethyl acetate
- Amount / concentration applied:
- 30 µl per insert
- Duration of treatment / exposure:
- 60 min at room temperature
- Observation period (in vivo):
- post-exposure incubation: 16 hours (37°C, 5% CO2, maximum humidity)
- Number of animals or in vitro replicates:
- not applicable
- Details on study design:
- The irritation potential of the test item is assessed by determination of its cytotoxic effect on an reconstructed human ocular epithelia. The test principle is based on the MTT assay reflecting the cell viability after exposure of the cornea equivalent to topically applied test item.
Tests were performed in triplets. The test item was applied at a 100% concentration, i.e. 30 µl per insert, for 60 min at room temperature. After the exposure period the inserts were washed carefully with PBS. After a post-exposure incubation of 16 hours in the incubator (37 +/- 2 °C, 5 % CO2, maximum humidity) MTT reduction was performed. Cell viability was measured by the amount of MTT reduction, i.e. an OD value following exposure to the negative or positive control substances or the test item.
Positive control: 1H-1,2,4-Triazole-3-thiol (30 mg, plus 30 µl PBS for moistening) - Interpretation of results:
- other: irritant property in vitro
- Executive summary:
- An in vitro study for assessing ocular irritation of chemicals using
a human 3D-corneal epithelial (HCE) cell model was conducted with
Triphenylmethane-4,4',4''-triisocyanate. The cell model, routinely used by
the major Cosmetic and Pharmaceutical companies, has been prevalidated in
2004 (van Goethem et. al., Tox in Vitro 20, 2006, 1-17). The pure test
item (30 mg per insert) was applied topically to the reconstructed HCE
tissue. After an exposure period of 60 minutes followed by a 16 hours
post-treatment incubation period the cell viability was measured as about
3 % by the MTT conversion assay. A test item is predicted to be an ocular
irritant if the mean relative cell viability is ≤ 50 % after exposure.
Therefore it is concluded that Triphenylmethane-4,4´,4´´-triisocyanate is
an ocular irritant under the conditions of this test method.
Reference
It is not advisable to test isocyanates in aqueous vehicles. Therefore, ethyl acetate had been chosen to moisture the test item before application to the cornea epithelium. Ethyl acetate is classified as an eye irritant which was confirmed by the results of this assay. The results of this assay show that the test substance Triphenylmethane-4,4’,4’’-triisocyanate also has an irritant effect, which however increases the irritant property of ethyl acetate.
Therefore the test item was detected as irritant to the cornea epithelium under the conditions of this test (s. Table 1)
Table1: Summary of results
Compound |
Cell Viability [%]
|
Evaluation |
negative control PBS |
100.00 |
non-irritant |
positive control 1H-1,2,4 -Triazole-3 -thiol |
24.41 |
irritant |
test substance |
2.76 |
irritant |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
Skin irritation:
Triphenylmethane-4,4',4''-triisocyanate (applied as a 27% solution in ethyl acetate) was shown to be irritating to the rabbit's skin in a study performed according to OECD TG 404. Due to light brown discolouration of the application area no evaluation of erythema and oedeme formation was possible in all 3 animals from the time point of patch removal to 8 days after patch removal. Thereafter the erythema/oedema score was 0 in all animals. On the other hand induration, laceration and peeling was observed in all animals whereas the onset of the effects differ from 24 hours to 5 days after patch removal. All effects were reversible within 13days after patch removal. No systemic intolerance reactions were observed.
A study for predicting non-specific, corrosive potential of Triphenylmethane-4,4',4''-triisocyanate by using reconstructed human skin (OECD TG 431) was performed. For the determination of time related cytotoxic effects the incubation periods were 3 min. and 60 min. The MTT (Methylthiazoletetrazolium) viability test results (3 min.: 108% viability; 60 min.: 24% viability compared to NaCl treated skin inserts) showed, that the test item has no corrosive property under the conditions of the assay used.
Eye irritation:
Triphenylmethane-4,4',4''-triisocyanate (applied as a 27% solution in ethyl acetate) shows irritating effects in rabbit eyes in a study performed according to OECD TG 405. The ocular reactions were restricted to 2/3 animals and were reversible within 5 days at the latest. Systemic effects were not observed.
An in vitro study for assessing ocular irritation of chemicals using a human 3D-corneal epithelial (HCE) cell model was conducted with Triphenylmethane-4,4',4''-triisocyanate. The cell model, routinely used by the major Cosmetic and Pharmaceutical companies, has been prevalidated in 2004 (van Goethem et. al., Tox in Vitro 20, 2006, 1-17). The pure test item (30 mg per insert) was applied topically to the reconstructed HCE tissue. After an exposure period of 60 minutes followed by a 16 hours post-treatment incubation period the cell viability was measured as about 3 % by the MTT conversion assay. A test item is predicted to be an ocular irritant if the mean relative cell viability is ≤ 50 % after exposure. Therefore it is concluded that Triphenylmethane-4,4´,4´´-triisocyanate is an ocular irritant under the conditions of this test method.
Respiratory Irritation:
Triphenylmethane-4,4',4''-triisocyanateaerosol was proven to be respiratory irritating. In a pulmonary irritant potency study (TRGS 430; OECD TG 403; see IUCLID chapter 7.2.2) with aerosolizedTriphenylmethane-4,4',4''-triisocyanate, rats showed signs suggestive of respiratory tract irritation at concentrations of 1.9 mg/m³ and above. Moreover, a subacute inhalation study with aerosolized Triphenylmethane-4,4',4''-triisocyanate (OECD TG 412, see IUCLID chapter 7.5.2) revealed changes which were related to portal-of-entry, local irritant effects (larynx, airways and alveoli).
Justification for selection of skin irritation / corrosion endpoint:
The existing study in laboratory animal with the trade product (27% Triphenylmethane-4,4',4''-triisocyanate in ethyl acetate) provide sound conclusive evidence that the substance is an irritant. Corrosivity of Triphenylmethane-4,4',4''-triisocyanate concentrations greater 27% was excluded by in vitro testing.
Justification for selection of eye irritation endpoint:
The existing study in laboratory animal with the trade product (27% Triphenylmethane-4,4',4''-triisocyanate in ethyl acetate) provide sound conclusive evidence that the substance is a non-irritant. But by in vitro testing (HCE assay) the solvent free test item was irritating.
Effects on skin irritation/corrosion: irritating
Effects on eye irritation: irritating
Effect level: empty Endpoint conclusion: Adverse effect observed
Justification for classification or non-classification
Skin irritation:
No corrosive properties were demonstrated in an in vitro test for Triphenylmethane-4,4´,4´´-triisocyanate and an existing study on irritation and corrosion in laboratory animals provides sound conclusive evidence that a solution of 27% Triphenylmethane-4,4',4''-triisocyanate in ethyl acetate is an irritant:
According to EU-Directive 67/548/EEC, Annex VI Triphenylmethane-4,4',4''-triisocyanate shall be classified as irritant.
According to Regulation (EC) No 1272/2008, Annex I, Triphenylmethane-4,4',4''-triisocyanate shall be allocated to Category 2: Irritant.
Eye irritation:
While an existing study on eye irritation in laboratory animals with a solution of 27% Triphenylmethane-4,4',4''-triisocyanate in ethyl acetat demonstrates irritating effects which are not classifiable.
A validated in vitro test provides evidence that Triphenylmethane-4,4´,4´´-triisocynate is an eye irritant.
According to EU-Directive 67/548/EEC, Annex VI Triphenylmethane-4,4',4''-triisocyanate shall be classified as irritating to the eyes.
According to Regulation (EC) No 1272/2008, Annex I, Triphenylmethane-4,4',4''-triisocyanate shall be allocated to Category 2: (irritating to eyes).
Respiratory irritation:
The inhalation studies (see chapter IUCLID Chapter 7.2.2 and 7.5.2) indicate that aerosolized Triphenylmethane-4,4',4''-triisocyanate (dust) causes respiratory tract irritation.
According to EU-Directive 67/548/EEC, Annex VI Triphenylmethane-4,4',4''-triisocyanate shall be classified as irritating to respiratory system
According to Regulation (EC) No 1272/2008, Annex I, Triphenylmethane-4,4',4''-triisocyanate shall be allocated to STOT SE Category 3 for respiratory irritation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.